KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) Net Margin (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Net Margin for 9 consecutive years, with 24.13% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 2334.0% to 24.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.92% through Dec 2025, down 1253.0% year-over-year, with the annual reading at 4.92% for FY2025, 1253.0% down from the prior year.
  • Net Margin hit 24.13% in Q4 2025 for Elanco Animal Health, down from 2.99% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 35.34% in Q3 2024 to a low of 102.62% in Q3 2023.
  • Historically, Net Margin has averaged 7.86% across 5 years, with a median of 4.69% in 2021.
  • Biggest five-year swings in Net Margin: tumbled -9629bps in 2023 and later skyrocketed 13796bps in 2024.
  • Year by year, Net Margin stood at 9.44% in 2021, then increased by 4bps to 9.04% in 2022, then tumbled by -51bps to 13.62% in 2023, then skyrocketed by 94bps to 0.78% in 2024, then tumbled by -2976bps to 24.13% in 2025.
  • Business Quant data shows Net Margin for ELAN at 24.13% in Q4 2025, 2.99% in Q3 2025, and 0.89% in Q2 2025.